title: Biological activity of barbados cherry (acerola fruits, fruit of Malpighia emarginata DC) extracts and fractions.
abstract: Fractionation of barbados cherry (acerola fruit, a fruit of Malpighia emarginata DC.) extracts were performed by organic solvent extractions and column chromatographies, using two extraction methods. Higher cytotoxic activity was concentrated in fractions A4 and A6 (acetone extract), and H3 and HE3 (hexane extract). These four fractions showed higher cytotoxic activity against tumor cell lines such as human oral squamous cell carcinoma (HSC-2) and human submandibular gland carcinoma (HSG), when compared with that against normal cells such as human periodontal ligament fibroblasts (HPLF) and human gingival fibroblasts (HGF). HE2 (hexane extract), AE2 (ethyl acetate extract), AE3, AE4, AE5, A8, A9 and A10 showed some relatively higher anti-bacterial activity on the Gram-positive Staphylococcus epidermidis ATCC 1228 but were ineffective on the representative Gram-negative species E. coli and Ps. aeruginosa. The fractions were inactive against Helicobacter pylori, two representative Candida species, and human immunodeficiency virus (HIV). H3, H4 and HE3, which displayed higher tumor-specific cytotoxicity also showed higher multidrug resistance (MDR) reversal activity, than (+/-)-verapamil as positive control. ESR spectroscopy shows that the radical-mediated oxidation is not involved in the induction of tumor-specific cytotoxic activity. The tumor specific cytotoxic activity and MDR reversal activity of barbados cherry may suggest its possible application for cancer therapy.
authors.affiliation: Meiji Pharmaceutical University, Noshio, Kiyose, Tokyo, Japan. motohasi@my-pharm.ac.jp
authors.forename: Noboru
authors.initials: N
authors.lastname: Motohashi
authors.forename: Hidetsugu
authors.initials: H
authors.lastname: Wakabayashi
authors.forename: Teruo
authors.initials: T
authors.lastname: Kurihara
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Fukushima
authors.forename: Tomoko
authors.initials: T
authors.lastname: Yamada
authors.forename: Masami
authors.initials: M
authors.lastname: Kawase
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Sohara
authors.forename: Satoru
authors.initials: S
authors.lastname: Tani
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Shirataki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Sakagami
authors.forename: Kazue
authors.initials: K
authors.lastname: Satoh
authors.forename: Hideki
authors.initials: H
authors.lastname: Nakashima
authors.forename: Annamária
authors.initials: A
authors.lastname: Molnár
authors.forename: Gabriella
authors.initials: G
authors.lastname: Spengler
authors.forename: Nóra
authors.initials: N
authors.lastname: Gyémánt
authors.forename: Katalin
authors.initials: K
authors.lastname: Ugocsai
authors.forename: Joseph
authors.initials: J
authors.lastname: Molnár
mesh_terms: D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects; D045744:Cell Line, Tumor / Q000187:drug effects; D018432:Drug Resistance, Multiple; D005347:Fibroblasts / Q000187:drug effects; D005638:Fruit; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006678:HIV / Q000187:drug effects; D006801:Humans; D029581:Malpighiaceae; D008826:Microbial Sensitivity Tests; D008517:Phytotherapy; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts